Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Schattenberg
L Stump

Showing results (91-100 of 392) with videos related to

Pageof 40
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2025
Impact of PNPLA3 I148M on Drug-Induced Hepatocellular Liver Injury: A Systematic Review and Meta-AnalysisAlexandra Gatzios, Lorna Marchandise, Hannes Hagström, et al.
Free Radical Biology & Medicine|March 13, 2012
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytesJörn M Schattenberg, Marcus A Wörns, Tim Zimmermann, et al.
Hepatology Communications|September 14, 2020
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionChristian Labenz, Yvonne Huber, Maurice Michel, et al.
European Journal of Gastroenterology & Hepatology|August 16, 2020
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysisChristian Labenz, Gerrit Toenges, Marcus-Alexander Wörns, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver DiseaseNicola Pugliese, Vincent Wai-Sun Wong, Jörn M Schattenberg, et al.
European Journal of Internal Medicine|April 28, 2026
Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statementReinhold Kreutz, Ali Canbay, Martin Haluzik, et al.
Journal of Cardiovascular Pharmacology|February 1, 1994
Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogsB P Damiano, E C Giardino, B J Haertlein, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarctionJ J Lynch, A A Wallace, G L Stump, et al.
Advances in Therapy|July 9, 2026
Qualitative Evaluation of Fatigue and Pruritus Among Patients with Primary Biliary CholangitisCynthia Levy, Betsy Williams, France Ginchereau Sowell, et al.
Hepatology Communications|October 27, 2023
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib studyEric J Lawitz, Thomas Reiberger, Jörn M Schattenberg, et al.
Pageof 40

Showing results (91-100 of 392) with videos related to

Sort By:
Pageof 40
Liver International : Official Journal of the International Association for the Study of the Liver|August 25, 2025
Impact of PNPLA3 I148M on Drug-Induced Hepatocellular Liver Injury: A Systematic Review and Meta-AnalysisAlexandra Gatzios, Lorna Marchandise, Hannes Hagström, et al.
Free Radical Biology & Medicine|March 13, 2012
The role of death effector domain-containing proteins in acute oxidative cell injury in hepatocytesJörn M Schattenberg, Marcus A Wörns, Tim Zimmermann, et al.
Hepatology Communications|September 14, 2020
Nonalcoholic Fatty Liver Disease Increases the Risk of Anxiety and DepressionChristian Labenz, Yvonne Huber, Maurice Michel, et al.
European Journal of Gastroenterology & Hepatology|August 16, 2020
Liver injury in patients with severe acute respiratory syndrome coronavirus-2 infection: a systematic review and meta-analysisChristian Labenz, Gerrit Toenges, Marcus-Alexander Wörns, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|September 16, 2023
Accuracy, Reliability, and Comprehensibility of ChatGPT-Generated Medical Responses for Patients With Nonalcoholic Fatty Liver DiseaseNicola Pugliese, Vincent Wai-Sun Wong, Jörn M Schattenberg, et al.
European Journal of Internal Medicine|April 28, 2026
Assessment and management of cardiovascular-kidney-liver metabolic-syndrome in the primary care setting: A multidisciplinary consensus statementReinhold Kreutz, Ali Canbay, Martin Haluzik, et al.
Journal of Cardiovascular Pharmacology|February 1, 1994
Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogsB P Damiano, E C Giardino, B J Haertlein, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1996
Differential efficacy of the class III agent MK-499 against programmed stimulation-induced and ischemic-induced ventricular arrhythmias in a canine model of previous myocardial infarctionJ J Lynch, A A Wallace, G L Stump, et al.
Advances in Therapy|July 9, 2026
Qualitative Evaluation of Fatigue and Pruritus Among Patients with Primary Biliary CholangitisCynthia Levy, Betsy Williams, France Ginchereau Sowell, et al.
Hepatology Communications|October 27, 2023
Safety and pharmacokinetics of BI 685509, a soluble guanylyl cyclase activator, in patients with cirrhosis: A randomized Phase Ib studyEric J Lawitz, Thomas Reiberger, Jörn M Schattenberg, et al.
Pageof 40